University Startup PvP Biologics Acquired by Takeda Pharmaceutical Company
By Lisa Howard PvP Biologics, a startup formed around technology developed at the University of Washington and the University of California, Davis, announced on February 26 that it has been acquired by Takeda Pharmaceutical Company Limited. The acquisition comes after the conclusion of a Phase 1 proof-of-mechanism study of an investigational medicine, TAK-062, also known as Kuma062, […]

